Synergistic targeting of Sp1, a critical transcription factor for myeloma cell growth and survival, by panobinostat and proteasome inhibitors
Ariunzaya Bat‐Erdene(Tokushima University), Masahiro Abe(Tokushima University)
Cited by 20
Related Papers
Comparison of the Protective Effect of N-Acetylcysteine by Different Treatments on Rat Myocardial Ischemia-Reperfusion Injury
|Journal of Pharmacological Sciences|2008|55
Effective impairment of myeloma cells and their progenitors by blockade of monocarboxylate transportation
|Oncotarget|2015|40
The Roles of ROS Generation in RANKL-Induced Osteoclastogenesis: Suppressive Effects of Febuxostat
|Cancers|2020|39
Unique anti‐myeloma activity by thiazolidine‐2,4‐dione compounds with Pim inhibiting activity
|British Journal of Haematology|2018|20
The Xanthine Oxidase Inhibitor Febuxostat Suppresses Adipogenesis and Activates Nrf2
|Antioxidants|2023|18